山东药玻(600529) - 2014 Q1 - 季度财报
SPGSPG(SH:600529)2014-04-21 16:00

Financial Performance - Operating revenue for the first quarter was CNY 390,024,307.40, representing a year-on-year growth of 9.19%[10] - Net profit attributable to shareholders decreased to CNY 29,899,737.94, down 4.91% from the same period last year[10] - Total operating revenue for the first quarter of 2014 was CNY 390,024,307.40, an increase of 9.2% compared to CNY 357,205,871.04 in the same period last year[26] - Total operating costs rose to CNY 349,820,478.22, up 10.6% from CNY 316,231,370.01 year-over-year[26] - Net profit for the first quarter was CNY 29,899,737.94, a decrease of 4.9% from CNY 31,443,301.37 in the previous year[26] - Basic and diluted earnings per share remained stable at CNY 0.12, unchanged from the same period last year[29] Cash Flow - Net cash flow from operating activities increased significantly by 64.14% to CNY 43,924,546.87 compared to the previous year[10] - Cash flow from operating activities generated a net inflow of CNY 43,924,546.87, significantly higher than CNY 26,760,705.46 in the previous year[33] - The net cash flow from operating activities increased to ¥44,220,744.62, compared to ¥23,012,991.61 in the previous period, representing an increase of approximately 92.1%[37] - Total cash inflow from operating activities was ¥390,908,750.07, up from ¥387,015,918.87, indicating a slight increase of about 0.75%[37] - Cash outflow from operating activities decreased to ¥346,688,005.45 from ¥364,002,927.26, a reduction of approximately 4.7%[37] - The ending cash and cash equivalents balance was ¥156,191,723.95, compared to ¥126,977,067.40 at the end of the previous period, reflecting an increase of approximately 23.0%[38] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 2,708,502,230.32, a slight increase of 0.11% compared to the end of the previous year[10] - Total assets increased to CNY 2,708,502,230.32 from CNY 2,705,463,004.13, reflecting a slight growth of 0.04%[20] - Current assets rose to CNY 1,439,004,969.52, up from CNY 1,424,464,099.28, indicating an increase of 1.03%[20] - Total liabilities decreased to CNY 650,122,430.15 from CNY 675,480,302.10, a reduction of 3.73%[21] - Current liabilities totaled CNY 650,122,430.15, down from CNY 675,480,302.10, showing a decrease of 3.73%[21] - Shareholders' equity increased to CNY 2,058,379,800.17 from CNY 2,029,982,702.03, reflecting a growth of 1.45%[21] - Undistributed profits rose to CNY 1,008,673,332.22 from CNY 978,773,594.28, an increase of 3.66%[21] - Non-current assets totaled CNY 1,269,497,260.80, down from CNY 1,280,998,904.85, indicating a decrease of 0.73%[20] Expenses - Financial expenses decreased by CNY 1,721,308.11, a reduction of 60.46% attributed to decreased exchange losses[16] - Sales expenses decreased slightly to CNY 31,381,634.99 from CNY 32,360,470.10 year-over-year[26] - Financial expenses decreased significantly to CNY 1,125,476.40 from CNY 2,846,784.51 in the previous year[26] - The company reported an increase in management expenses to CNY 22,124,442.12, up from CNY 20,365,627.23 year-over-year[26] - The company incurred an asset impairment loss of CNY 747,962.85, compared to a gain of CNY 256,058.48 in the previous year[26] - Tax payable increased by CNY 5,873,420.84, reflecting a significant rise of 283.55% due to increased tax obligations[16] Shareholder Information - The company's total number of shareholders reached 27,009 at the end of the reporting period[14]